HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disorders.

Abstract
We report the case of a 35-year-old male patient suffering from a clinical and radiological manifestation of a transverse myelitis associated with antiphospholipid antibodies. After a challenging diagnosis the patient improved substantially due to immunosuppressive treatment. The demyelinating spinal cord lesion and the impressive therapeutic outcome may support the possibility of a direct binding of antiphospholipid antibodies to CNS antigens and consequently leading to a neuroimmunological pathomechanism distinct from the well-known pro-thrombotic effect of antiphospholipid antibodies. In terms of clinical routine diagnostic this case report highlights a rare but notable differential diagnosis of Multiple Sclerosis-like syndromes.
AuthorsKlaus Berek, Elena Fava, Anne Zinganell, Harald Hegen, Michael Auer, Sebastian Wurth, Paul Rhomberg, Florian Deisenhammer, Franziska Di Pauli
JournalMultiple sclerosis and related disorders (Mult Scler Relat Disord) Vol. 45 Pg. 102405 (Oct 2020) ISSN: 2211-0356 [Electronic] Netherlands
PMID32707532 (Publication Type: Case Reports)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Antiphospholipid
  • Immunosuppressive Agents
Topics
  • Adult
  • Antibodies, Antiphospholipid
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents
  • Male
  • Multiple Sclerosis
  • Myelitis, Transverse (diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: